Carleton Connects: Wes Sundquist '81
Carleton Connects: Wes Sundquist '81

The research lab of Wes Sundquist ’81 made discoveries that helped Gilead Sciences create lenacapavir, a drug that protects individuals at risk from HIV infection and that offers the potential to alter the course of the ongoing HIV pandemic. Wes will summarize his lab’s work, current threats to research funding, and the challenges in translating new discoveries into products that drive economic growth and help people to live better lives.



 I own and retain the copyright
  • Title Carleton Connects: Wes Sundquist '81
  • Upload Date December 1, 2025 5:57pm
  • Date
  • Description The research lab of Wes Sundquist ’81 made discoveries that helped Gilead Sciences create lenacapavir, a drug that protects individuals at risk from HIV infection and that offers the potential to alter the course of the ongoing HIV pandemic. Wes will summarize his lab’s work, current threats to research funding, and the challenges in translating new discoveries into products that drive economic growth and help people to live better lives.
  • Licensing I own and retain the copyright
  • Permitted Uses Copyrighted Material: No use without written permission from owner.
  • Department or Office Alumni Relations
  • Keywords Carleton Connects
  • Rating
  • Names
  • Creator
  • Course Number
  • Access Restrictions
  • Interviewer
  • Narrator
  • Original Format Location
  • Related Collection
  • Transcript
  • Archives UnitID
  • Year Created 2025
  • Item State
  • Course Subject
  • Frame Rate 25
  • Frame Mode Smpte_25
Register